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Introductory Article
Guidelines for theManagement of Degenerative
Cervical Myelopathy and Spinal Cord Injury:
An Introduction to a Focus Issue
Michael G. Fehlings, MD, PhD, FRCSC, FACS1,2,
Brian K. Kwon, MD, PhD3, and Lindsay A. Tetreault, PhD1,4
Abstract
Study Design: Introduction to a guidelines project.
Objectives: The objective of this focus issue is to present guidelines that outline how to best manage patients with degenerative
cervical myelopathy (DCM) and spinal cord injury (SCI). Topics addressed in this focus issue include: 1) management strategies for
patients with mild, moderate and severe DCM; and 2a) timing of surgical decompression; b) the use of methylprednisolone
sodium succinate; c) the type and timing of anticoagulation strategies; d) the role of magnetic resonance imaging in clinical decision
making and outcome prediction; and e) the type and timing of rehabilitation in patients with SCI.
Methods: Systematic reviews were conducted to address key clinical questions and to synthesize the current body of evidence. A
multidisciplinary guideline development group used the results of these reviews, along with their clinical expertise, to develop
clinical practice guidelines, in a process that adhered to methodology proposed by the Grades of Recommendation, Assessment,
Development and Evaluation (GRADE) Working Group.
Results: The multidisciplinary guideline development group combined the systematic review findings with their clinical expertise
and opinions to formulate recommendations on how to manage patients with DCM and SCI.
Conclusions: These guidelines will serve as tools to assist clinicians in their decision making by offering a perspective that
combines the available evidence, expertise from a variety of clinicians, and patient values.
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Introduction
Injury to the spinal cord, and its resultant neurologic conse-
quences, remains one of the most challenging, intractable, and
poorly understood medical conditions. Such injuries occur
along a broad continuum, from the sudden catastrophic paraly-
sis caused by a high-speed motor vehicle accident to the slow
and indolent neurologic decline from chronic degenerative
spinal stenosis. While both acute traumatic and chronic com-
pressive spinal cord pathologies have been recognized for cen-
turies, many fundamental questions remain about their optimal
management. These include seemingly basic questions such as
What is the natural history of neurologic decline (in chronic
degenerative cervical myelopathy [DCM)] or recovery [in
acute traumatic spinal cord injury; SCI])? What are the best
diagnostic modalities and how do these inform treatment deci-
sions? Intrinsically linked to these enquiries is the basic
question surrounding the role of decompressive surgery in sta-
bilizing or improving neurologic function. What surgery (if
any) should be performed? What are the clinical results of such
an invasive intervention in terms of altering the natural course
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of neurologic recovery or decline? If it is to be performed,
when would be the optimal timing for surgical intervention?
Furthermore, questions remain about the efficacy of other
potential treatments aside from surgical decompression. Might
there be medical therapies that could influence neurologic out-
come and/or rehabilitative interventions that could promote
functional recovery? This focus issue aims to address these
questions in the context of both DCM and acute SCI.
In this focus issue, DCM and acute traumatic SCI were
approached in a 2-step fashion. First, systematic reviews were
rigorously performed to synthesize the available literature,
address the aforementioned clinical questions, and provide the
reader with a summary of the current evidence. For methodo-
logic robustness, consistency, and in an attempt to minimize
bias, these reviews were conducted by Spectrum Research,
who have considerable experience in this arena. Second, a
multidisciplinary guideline development group used the results
from these systematic reviews as the scientific basis for devel-
oping a clinical practice guideline in a process that adhered to
methodology proposed by the Grades of Recommendation,
Assessment, Development and Evaluation (GRADE) Working
Group. This increasingly utilized methodology entails a con-
sensus building approach that extends beyond merely the
strength of the available scientific evidence and considers fac-
tors such as feasibility, acceptability, and the estimated balance
of favorable and unfavorable consequences. The guideline
development process also involved a spectrum of stakeholders
and therefore reflects perspectives of not just surgeons but also
primary care physicians, neurologists, rheumatologists, rehabi-
litation specialists, and patients.
For DCM (an all-encompassing term proposed to describe
all forms of degenerative changes to the spine, including cer-
vical spondylotic myelopathy and ossification of the posterior
longitudinal ligament), this guideline summarized the most
recent clinical research in this area and developed recommen-
dations to guide clinicians in the management of patients with
mild, moderate, and severe myelopathy, as well as nonmyelo-
pathic individuals with evidence of cord compression. For
acute traumatic SCI, this guideline revisited some of the most
controversial questions of management, including the timing of
surgical decompression and the use of high-dose methylpred-
nisolone. For these contentious issues, results from rigorously
conducted systematic reviews were considered, as well as
patient preferences and other important factors included in the
GRADE methodology. It is acknowledged that the recommen-
dations that have emerged from this process will not necessa-
rily end the controversy in these areas, but will likely stimulate
further discussion on the optimal management of acute SCI
patients. Other topics in the SCI guideline include the role of
magnetic resonance imaging in clinical decision making and
prognostication, the type and timing of prophylactic anticoa-
gulation, and the use of various rehabilitation strategies.
Obviously, it would be ideal if the clinical and scientific
evidence around these issues was so compelling that there was
little doubt as to what to recommend in a clinical practice
guideline (which of course would probably obviate the need
for generating such recommendations). The reality is that
uncertainty exists, and that the strength of the available litera-
ture for many of our recommendations prevents the develop-
ment of a forceful clinical practice guideline. Furthermore, the
state of the available literature does not absolve the clinician
from the tough treatment choices they must make for their
patients with DCM or acute traumatic SCI. Ultimately, the goal
of these guidelines is to provide tools that could assist clini-
cians in their decision making by offering a perspective that
combines the available evidence, expertise from a variety of
clinicians, and patient values. The hope and expectation is that
further research in these important areas will contribute to the
evolution of these guidelines for the management of both DCM
and traumatic SCI.
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